The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2022
Filed:
Oct. 15, 2021
Applicants:
Ablynx N.v., Zwijnaarde, BE;
Sanofi, Paris, FR;
Inventors:
Heidi Rommelaere, Ghent, BE;
Christian Asbrand, Frankfurt Am Main, DE;
Ann Brigé, Ertvelde, BE;
Sigrid Cornelis, Sint Martens Latem, BE;
Eric Lorent, Zwijnaarde, BE;
Assignees:
Ablynx N.V., Zwijnaarde, BE;
Sanofi, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61P 37/06 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61P 17/00 (2018.01); A61P 19/02 (2018.01); A61P 37/06 (2018.01); C07K 16/18 (2013.01); C07K 16/241 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present technology aims at providing a novel type of drug. Specifically, the present technology provides polypeptides comprising at least three immunoglobulin single variable domains (ISVDs), characterized in that at least one ISVD binds to TNFα and at least two ISVDs bind to IL-23. The present technology also provides nucleic acids, vectors and compositions.